In T2D patients, the presence of the second-phase hyperinsulinemia, together with the flat post-peak activity of IRS2, contributes to the hyperactivity of aPKC in the liver of these patients (Figs. 5, 6). This evidence concerns the gene IRS2 and type 2 diabetes mellitus.